CODX Co-Diagnostics Inc

Price (delayed)

$10.28

Market cap

$294.7M

P/E Ratio

5.59

Dividend/share

N/A

EPS

$1.84

Enterprise value

$236.91M

Highlights
The stock's price to earnings (P/E) is 76% less than its last 4 quarters average of 23.0
The company's gross profit rose by 27% QoQ

Key stats

What are the main financial stats of CODX
Market
Shares outstanding
28.67M
Market cap
$294.7M
Enterprise value
$236.91M
Valuations
Price to earnings (P/E)
5.59
Price to book (P/B)
3.86
Price to sales (P/S)
3.17
EV/EBIT
4.43
EV/EBITDA
4.41
EV/Sales
2.55
Earnings
Revenue
$93.03M
EBIT
$53.52M
EBITDA
$53.7M
Free cash flow
$40.96M
Per share
EPS
$1.84
Free cash flow per share
$1.43
Book value per share
$2.66
Revenue per share
$3.25
TBVPS
$2.83
Balance sheet
Total assets
$81.12M
Total liabilities
$4.86M
Debt
$0
Equity
$76.26M
Working capital
$74.83M
Liquidity
Debt to equity
0
Current ratio
18.37
Quick ratio
16.77
Net debt/EBITDA
-1.08
Margins
EBITDA margin
57.7%
Gross margin
79.2%
Net margin
55.3%
Operating margin
57.1%
Efficiency
Return on assets
83.7%
Return on equity
88.9%
Return on invested capital
233.6%
Return on capital employed
69.7%
Return on sales
57.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CODX stock price

How has the Co-Diagnostics stock price performed over time
Intraday
1.08%
1 week
4.58%
1 month
25.21%
1 year
-62.78%
YTD
10.54%
QTD
24.61%

Financial performance

How have Co-Diagnostics's revenue and profit performed over time
Revenue
$93.03M
Gross profit
$73.65M
Operating income
$53.11M
Net income
$51.44M
Gross margin
79.2%
Net margin
55.3%
Co-Diagnostics's operating margin has soared by 118% YoY and by 2.1% from the previous quarter
The company's net margin has surged by 117% YoY but it fell by 3% QoQ
CODX's operating income is up by 27% from the previous quarter
The company's gross profit rose by 27% QoQ

Growth

What is Co-Diagnostics's growth rate over time

Valuation

What is Co-Diagnostics stock price valuation
P/E
5.59
P/B
3.86
P/S
3.17
EV/EBIT
4.43
EV/EBITDA
4.41
EV/Sales
2.55
The stock's price to earnings (P/E) is 76% less than its last 4 quarters average of 23.0
CODX's EPS is up by 16% since the previous quarter
The P/B is 48% below the last 4 quarters average of 7.4
The equity rose by 14% since the previous quarter
The P/S is 64% below the last 4 quarters average of 8.8
The revenue has grown by 25% from the previous quarter

Efficiency

How efficient is Co-Diagnostics business performance
CODX's return on invested capital has surged by 150% year-on-year and by 2.2% since the previous quarter
CODX's return on sales has surged by 117% year-on-year
CODX's return on equity is down by 9% since the previous quarter
The ROA has contracted by 9% from the previous quarter

Dividends

What is CODX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CODX.

Financial health

How did Co-Diagnostics financials performed over time
Co-Diagnostics's quick ratio has increased by 27% QoQ and by 9% YoY
The current ratio has increased by 21% from the previous quarter and by 12% YoY
The company's debt is 100% lower than its equity
The equity rose by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.